Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 4 | 2024 | 876 | 1.220 |
Why?
|
| Drug Discovery | 7 | 2024 | 174 | 1.160 |
Why?
|
| Ligands | 5 | 2021 | 495 | 1.070 |
Why?
|
| Receptors, IgG | 2 | 2023 | 62 | 0.980 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2024 | 608 | 0.940 |
Why?
|
| Antigen-Antibody Complex | 1 | 2023 | 64 | 0.820 |
Why?
|
| Polypharmacology | 3 | 2020 | 4 | 0.800 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2023 | 22 | 0.800 |
Why?
|
| Gold | 1 | 2022 | 56 | 0.760 |
Why?
|
| AIDS Serodiagnosis | 1 | 2021 | 56 | 0.690 |
Why?
|
| Spermatozoa | 1 | 2023 | 243 | 0.690 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 229 | 0.660 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 451 | 0.610 |
Why?
|
| Signal Transduction | 5 | 2024 | 4718 | 0.530 |
Why?
|
| Mebendazole | 1 | 2016 | 7 | 0.520 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2016 | 8 | 0.520 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 135 | 0.470 |
Why?
|
| ras Proteins | 1 | 2016 | 146 | 0.450 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 168 | 0.440 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 1829 | 0.440 |
Why?
|
| Models, Molecular | 2 | 2021 | 1120 | 0.430 |
Why?
|
| Contraceptive Agents, Male | 2 | 2024 | 35 | 0.390 |
Why?
|
| Receptors, Fc | 2 | 2023 | 33 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 3 | 2023 | 728 | 0.330 |
Why?
|
| RNA, Long Noncoding | 2 | 2023 | 240 | 0.300 |
Why?
|
| HIV Infections | 1 | 2021 | 2049 | 0.300 |
Why?
|
| DNA | 5 | 2024 | 1479 | 0.270 |
Why?
|
| Quantitative Structure-Activity Relationship | 2 | 2016 | 15 | 0.260 |
Why?
|
| Molecular Docking Simulation | 2 | 2016 | 142 | 0.240 |
Why?
|
| Activin Receptors, Type I | 1 | 2024 | 35 | 0.220 |
Why?
|
| Glioblastoma | 2 | 2020 | 374 | 0.220 |
Why?
|
| Enzyme Activation | 2 | 2022 | 618 | 0.220 |
Why?
|
| Humans | 25 | 2024 | 132238 | 0.210 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2024 | 50 | 0.210 |
Why?
|
| Contraception | 1 | 2024 | 61 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 179 | 0.210 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2023 | 30 | 0.200 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 16 | 0.200 |
Why?
|
| Glycosylation | 1 | 2023 | 126 | 0.200 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2023 | 60 | 0.200 |
Why?
|
| Lipolysis | 1 | 2023 | 75 | 0.200 |
Why?
|
| Kynurenine | 1 | 2023 | 26 | 0.200 |
Why?
|
| Smad Proteins | 1 | 2023 | 43 | 0.200 |
Why?
|
| Animals | 12 | 2024 | 34845 | 0.200 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 351 | 0.190 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 100 | 0.190 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 10 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 14 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 175 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2021 | 124 | 0.170 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 97 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 74 | 0.170 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 90 | 0.170 |
Why?
|
| Mice | 9 | 2024 | 18502 | 0.170 |
Why?
|
| NF-kappa B | 1 | 2023 | 454 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 569 | 0.170 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 74 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 803 | 0.160 |
Why?
|
| Endometrium | 1 | 2023 | 277 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 305 | 0.160 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 34 | 0.160 |
Why?
|
| ARNTL Transcription Factors | 1 | 2020 | 45 | 0.160 |
Why?
|
| Pinocytosis | 1 | 2019 | 6 | 0.150 |
Why?
|
| Syndecan-1 | 1 | 2019 | 7 | 0.150 |
Why?
|
| Algorithms | 2 | 2024 | 1725 | 0.150 |
Why?
|
| Uterus | 1 | 2023 | 548 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 816 | 0.140 |
Why?
|
| Glycoproteins | 1 | 2020 | 377 | 0.130 |
Why?
|
| Structure-Activity Relationship | 3 | 2024 | 590 | 0.130 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 24 | 0.130 |
Why?
|
| Binding Sites | 2 | 2018 | 1256 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 90 | 0.130 |
Why?
|
| Logistic Models | 1 | 2021 | 1841 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2018 | 295 | 0.130 |
Why?
|
| Dasatinib | 1 | 2016 | 50 | 0.130 |
Why?
|
| Drug Design | 1 | 2017 | 161 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1285 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 806 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1204 | 0.110 |
Why?
|
| Pharmacology | 1 | 2014 | 7 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 664 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2021 | 916 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 549 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 333 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 391 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2024 | 322 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2552 | 0.090 |
Why?
|
| Software | 1 | 2016 | 732 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 3689 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3018 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1541 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 2062 | 0.070 |
Why?
|
| Male | 6 | 2024 | 65013 | 0.070 |
Why?
|
| Protein Binding | 2 | 2021 | 1734 | 0.060 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 689 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1963 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 34 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 13 | 0.050 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2023 | 56 | 0.050 |
Why?
|
| Carbon | 1 | 2024 | 94 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2510 | 0.050 |
Why?
|
| Rejuvenation | 1 | 2023 | 12 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 15 | 0.050 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2023 | 19 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 436 | 0.050 |
Why?
|
| Penicillins | 1 | 2023 | 155 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 66 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 96 | 0.050 |
Why?
|
| Protein Stability | 1 | 2023 | 168 | 0.050 |
Why?
|
| Gene Library | 1 | 2023 | 213 | 0.050 |
Why?
|
| Epithelium | 1 | 2023 | 354 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 169 | 0.050 |
Why?
|
| Adipocytes | 1 | 2023 | 182 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 423 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 28 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 107 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2023 | 208 | 0.040 |
Why?
|
| Endometriosis | 1 | 2024 | 175 | 0.040 |
Why?
|
| Protein Domains | 1 | 2022 | 260 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 110 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 182 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 2960 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 827 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 164 | 0.040 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 890 | 0.040 |
Why?
|
| Methylation | 1 | 2020 | 208 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 83 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 239 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2020 | 49 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 199 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 4687 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 203 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 722 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 93 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 138 | 0.040 |
Why?
|
| Female | 5 | 2024 | 70780 | 0.030 |
Why?
|
| Virus Replication | 1 | 2021 | 636 | 0.030 |
Why?
|
| Arginine | 1 | 2020 | 343 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 174 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1671 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 403 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2018 | 156 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 248 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 998 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 348 | 0.030 |
Why?
|
| Quinazolines | 1 | 2018 | 187 | 0.030 |
Why?
|
| Drug Industry | 1 | 2017 | 48 | 0.030 |
Why?
|
| PAX6 Transcription Factor | 1 | 2016 | 38 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2017 | 31 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 241 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1899 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3045 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2020 | 813 | 0.030 |
Why?
|
| Epigenomics | 1 | 2016 | 191 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 149 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1037 | 0.030 |
Why?
|
| Databases, Chemical | 1 | 2014 | 2 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1125 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2680 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 277 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1797 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 502 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 569 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3868 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2016 | 526 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 2724 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 2232 | 0.020 |
Why?
|
| Internet | 1 | 2014 | 406 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2398 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4758 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 2491 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 6250 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21482 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 29021 | 0.010 |
Why?
|